Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy

Hypertensive nephropathy is the second most frequent cause of end-stage renal disease in western societies. In previous experiments in our laboratory with proteomic analysis of renal parenchyma of SHR hypertensive animals, we identified two molecules, namely SGLT2 and CLIC4, associated with the deve...

Full description

Bibliographic Details
Main Authors: Georgios Barkas, Manousos Makridakis, Hariklia Gakiopoulou, Demetrios Vlahakos
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Data in Brief
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352340922000178
_version_ 1819279123427622912
author Georgios Barkas
Manousos Makridakis
Hariklia Gakiopoulou
Demetrios Vlahakos
author_facet Georgios Barkas
Manousos Makridakis
Hariklia Gakiopoulou
Demetrios Vlahakos
author_sort Georgios Barkas
collection DOAJ
description Hypertensive nephropathy is the second most frequent cause of end-stage renal disease in western societies. In previous experiments in our laboratory with proteomic analysis of renal parenchyma of SHR hypertensive animals, we identified two molecules, namely SGLT2 and CLIC4, associated with the development of hypertension. Here, we apply the methodology of targeted proteomic analysis in kidney biopsies from patients with hypertensive nephropathy to study the role of SGLT2 and CLIC4 in the pathogenesis of the disease. Relative quantification data of SGLT2 and CLIC4 via means of targeted proteomic analysis in human kidney biopsies from hypertensive patients and normotensive controls are reported. In addition, validation data of the proteomic results via immunofluorescence are presented. Renal tissue biopsies (N = 17) from archival material of patients with hypertensive nephropathy and normotensive controls were used. Targeted proteomic analysis was performed using the method: ``Parallel Reaction Monitoring'' (PRM) in renal parenchyma of hypertensive and normotensive patients for the selective identification of SGLT2 and CLIC4 and the relative quantification of their expression using proteotypic peptides for each protein. The expression of SGLT2 molecule was also confirmed by immunofluorescence followed by quantification of fluorescence intensity. According to PRM, the SGLT2 protein was found with reduced and the CLIC4 protein with increased expression levels in hypertensive patients compared to normotensive controls. Comparison of representative immunofluorescence images confirmed a decrease in the expression of SGLT2 in the brush border of proximal tubular epithelial cells in hypertensive patients. Our data show changes in the tubular compartment of the kidney and especially in the proximal tubules associated with the hypertensive nephropathy. The clinical significance of these findings should be further explored for the discovery and/or confirmation of novel therapeutic approaches and biomarkers in the development of hypertensive kidney disease.
first_indexed 2024-12-24T00:22:54Z
format Article
id doaj.art-70d82ecf1fd947188f7fe2d9b1dcb327
institution Directory Open Access Journal
issn 2352-3409
language English
last_indexed 2024-12-24T00:22:54Z
publishDate 2022-02-01
publisher Elsevier
record_format Article
series Data in Brief
spelling doaj.art-70d82ecf1fd947188f7fe2d9b1dcb3272022-12-21T17:24:32ZengElsevierData in Brief2352-34092022-02-0140107805Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathyGeorgios Barkas0Manousos Makridakis1Hariklia Gakiopoulou2Demetrios Vlahakos3Biomedical Research Foundation of the Academy of Athens, GreeceBiomedical Research Foundation of the Academy of Athens, Greece; Corresponding author.National and Kapodistrian University of Athens Medical School, Athens, GreeceNational and Kapodistrian University of Athens Medical School, Athens, GreeceHypertensive nephropathy is the second most frequent cause of end-stage renal disease in western societies. In previous experiments in our laboratory with proteomic analysis of renal parenchyma of SHR hypertensive animals, we identified two molecules, namely SGLT2 and CLIC4, associated with the development of hypertension. Here, we apply the methodology of targeted proteomic analysis in kidney biopsies from patients with hypertensive nephropathy to study the role of SGLT2 and CLIC4 in the pathogenesis of the disease. Relative quantification data of SGLT2 and CLIC4 via means of targeted proteomic analysis in human kidney biopsies from hypertensive patients and normotensive controls are reported. In addition, validation data of the proteomic results via immunofluorescence are presented. Renal tissue biopsies (N = 17) from archival material of patients with hypertensive nephropathy and normotensive controls were used. Targeted proteomic analysis was performed using the method: ``Parallel Reaction Monitoring'' (PRM) in renal parenchyma of hypertensive and normotensive patients for the selective identification of SGLT2 and CLIC4 and the relative quantification of their expression using proteotypic peptides for each protein. The expression of SGLT2 molecule was also confirmed by immunofluorescence followed by quantification of fluorescence intensity. According to PRM, the SGLT2 protein was found with reduced and the CLIC4 protein with increased expression levels in hypertensive patients compared to normotensive controls. Comparison of representative immunofluorescence images confirmed a decrease in the expression of SGLT2 in the brush border of proximal tubular epithelial cells in hypertensive patients. Our data show changes in the tubular compartment of the kidney and especially in the proximal tubules associated with the hypertensive nephropathy. The clinical significance of these findings should be further explored for the discovery and/or confirmation of novel therapeutic approaches and biomarkers in the development of hypertensive kidney disease.http://www.sciencedirect.com/science/article/pii/S2352340922000178Parallel Reaction Monitoring (PRM)ProteomicsImmunofluorescenceHypertensive nephropathyHuman Kidney BiopsiesSGLT2
spellingShingle Georgios Barkas
Manousos Makridakis
Hariklia Gakiopoulou
Demetrios Vlahakos
Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
Data in Brief
Parallel Reaction Monitoring (PRM)
Proteomics
Immunofluorescence
Hypertensive nephropathy
Human Kidney Biopsies
SGLT2
title Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
title_full Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
title_fullStr Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
title_full_unstemmed Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
title_short Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
title_sort targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy
topic Parallel Reaction Monitoring (PRM)
Proteomics
Immunofluorescence
Hypertensive nephropathy
Human Kidney Biopsies
SGLT2
url http://www.sciencedirect.com/science/article/pii/S2352340922000178
work_keys_str_mv AT georgiosbarkas targetedproteomicanalysisdatasetofarchivalcorehumankidneybiopsiestoinvestigatethebiologyofhypertensivenephropathy
AT manousosmakridakis targetedproteomicanalysisdatasetofarchivalcorehumankidneybiopsiestoinvestigatethebiologyofhypertensivenephropathy
AT harikliagakiopoulou targetedproteomicanalysisdatasetofarchivalcorehumankidneybiopsiestoinvestigatethebiologyofhypertensivenephropathy
AT demetriosvlahakos targetedproteomicanalysisdatasetofarchivalcorehumankidneybiopsiestoinvestigatethebiologyofhypertensivenephropathy